Compare Vipshop Holdings Ltd - ADR (VIPS) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vipshop Holdings Ltd - ADR vs Zoetis Inc — how do they compare? Vipshop Holdings Ltd - ADR trades at $14.46 (market cap $7.20B), while Zoetis Inc trades at $72.62 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 4.3× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.14%). Which is the better fit depends on your goals.
| VIPS | ZTS | |
|---|---|---|
Market Cap | $7.20B | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $20.68 | $156.76 |
52-Week Low | $12.92 | $71.91 |
Enterprise Value | $3.76B | $38.70B |
Dividend Yield | 4.14% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VIPS stock trades at $14.31, down 7.14% over 24 hours, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q1 2026 EPS of $0.68, meeting expectations, and maintains strong profitability with a net income margin of 7.07%. Recent news highlights growth initiatives, including an outlet strategy to boost performance amid industry challenges.
The outlook for VIPS is cautiously optimistic, supported by low valuation multiples like a P/E of 6.79 and a buy consensus from 53.57% of analysts. Risks include revenue stagnation and macroeconomic pressures, but the stock's discounted valuation may offer upside if growth resumes.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
